Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A44812 | 27237428 | Clin Gastroenterol Hepatol | Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification. | 2016 | Details |
| A44813 | 27236162 | Ann Hepatol | Elafibranor for the treatment of NAFLD: One pill, two molecular targets and multiple effects in a complex phenotype. | 2017 | Details |
| A44814 | 31041041 | Clin Liver Dis (Hoboken) | Epidemiology of nonalcoholic fatty liver disease: A primer. | 2016 | Details |
| A44815 | 27208083 | Toxicol Sci | 3,3',4,4',5-Pentachlorobiphenyl (PCB 126) Decreases Hepatic and Systemic Ratios of Epoxide to Diol Metabolites of Unsaturated Fatty Acids in Male Rats. | 2016 | Details |
| A44816 | 27198543 | Sci Rep | Erratum: A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet. | 2016 | Details |
| A44817 | 27193136 | J Am Assoc Nurse Pract | An evidence-based resource for the management of comorbidities associated with childhood overweight and obesity. | 2016 | Details |
| A44818 | 27189109 | Sci Rep | Chronic administration of Angelica sinensis polysaccharide effectively improves fatty liver and glucose homeostasis in high-fat diet-fed mice. | 2016 | Details |
| A44819 | 27184632 | Saudi J Gastroenterol | Is vitamin e or ursodeoxycholic acid a valid treatment option for nonalcoholic fatty liver disease in 2016? | 2016 | Details |
| A44820 | 27183465 | Nucl Med Biol | Efficient radiosynthesis and non-clinical safety tests of the TSPO radioprobe [(18)F]FEDAC: Prerequisites for clinical application. | 2016 | Details |
| A44821 | 27181498 | J Diabetes Investig | Managing non-alcoholic fatty liver disease in diabetes: Challenges and opportunities. | 2016 | Details |
| A44822 | 27177847 | Atherosclerosis | Corrigendum to "Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease" [Atherosclerosis 234 (2) (2014) 270-275]. | 2016 | Details |
| A44823 | 27173083 | Am J Obstet Gynecol | The association of early unexplained elevated alanine aminotransferase with large-for-gestational-age birthweight. | 2016 | Details |
| A44824 | 27173023 | Curr Vasc Pharmacol | Editorial: Resolution of Non-Alcoholic-Steatohepatitis. More than One Drug Needed? | 2016 | Details |
| A44825 | 27172353 | Semin Liver Dis | Epidemiology and Healthcare Burden of Acute-on-Chronic Liver Failure. | 2016 | Details |
| A44826 | 27155520 | Gastroenterology | Commonalities and Distinctions Between Alcoholic and Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A44827 | 28868447 | GE Port J Gastroenterol | A Bugs Battle on Behalf of the Liver. | 2016 | Details |
| A44828 | 27150216 | Mayo Clin Proc | In Reply-Diet and Activity Programs Are Ineffective in Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A44829 | 27150215 | Mayo Clin Proc | Diet and Activity Programs Are Ineffective in Nonalcoholic Steatohepatitis. | 2016 | Details |
| A44830 | 27146835 | Hepatol Int | NAFLD as a risk factor for HCC: new rules of engagement? | 2016 | Details |
| A44831 | 27142562 | Cancer | Is nonalcoholic fatty liver disease driving the increased incidence of liver cancer? | 2016 | Details |
| A44832 | 27140117 | Appl Opt | Polarization-dependent laser autofluorescence of the polycrystalline networks of blood plasma films in the task of liver pathology differentiation. | 2016 | Details |
| A44833 | 27139240 | Alcohol | Detection and qualitative analysis of fatty acid amides in the urine of alcoholics using HPLC-QTOF-MS. | 2016 | Details |
| A44834 | 27134669 | Therap Adv Gastroenterol | Coffee, caffeine and non-alcoholic fatty liver disease? | 2016 | Details |
| A44835 | 27134666 | Therap Adv Gastroenterol | Novel bile acid therapeutics for the treatment of chronic liver diseases. | 2016 | Details |
| A44836 | 27133033 | Biomed Pharmacother | Effects of endurance and endurance-strength exercise on biochemical parameters of liver function in women with abdominal obesity. | 2016 | Details |
| A44837 | 27124068 | Medicine (Baltimore) | Relationship Between Hepatic Steatosis and the Elevation of Aminotransferases in HBV-Infected Patients With HBe-Antigen Negativity and a Low Viral Load. | 2016 | Details |
| A44838 | 27116685 | Pathobiology | Chitotriosidase: A New Inflammatory Marker in Diabetic Complications. | 2016 | Details |
| A44839 | 27109980 | Transplant Proc | Adult Intestinal and Multivisceral Transplantation: Experience From a Single Center in the United Kingdom. | 2016 | Details |
| A44840 | 27108106 | Food Chem Toxicol | High calcium diet improves the liver oxidative stress and microsteatosis in adult obese rats that were overfed during lactation. | 2016 | Details |
| A44841 | 27102512 | J Am Coll Cardiol | Nonalcoholic Fatty Liver Disease and Incident Cardiac Events: The Multi-Ethnic Study of Atherosclerosis. | 2016 | Details |
| A44842 | 27100147 | Hepatology | Clinical advances in pediatric nonalcoholic fatty liver disease. | 2016 | Details |
| A44843 | 27099587 | Gastroenterol Hepatol (N Y) | Pathogenesis and Prevention of Hepatic Steatosis. | 2015 | Details |
| A44844 | 27097220 | PLoS One | Spaceflight Activates Lipotoxic Pathways in Mouse Liver. | 2016 | Details |
| A44845 | 27093595 | Expert Rev Gastroenterol Hepatol | Targeting endoplasmic reticulum stress in liver disease. | 2016 | Details |
| A44846 | 27091143 | Intern Emerg Med | Osmotic demyelination syndrome: plasmapheresis versus intravenous immunoglobulin? | 2016 | Details |
| A44847 | 27080068 | Magn Reson Med | Multisite, multivendor validation of the accuracy and reproducibility of proton-density fat-fraction quantification at 1.5T and 3T using a fat-water phantom. | 2016 | Details |
| A44848 | 27071046 | Semin Thromb Hemost | Alterations in Fibrin Structure in Patients with Liver Diseases. | 2016 | Details |
| A44849 | 27068170 | Dig Dis Sci | Editors' Introduction to the NAFLD and NASH Special Issue. | 2016 | Details |
| A44850 | 27063278 | Clin Liver Dis | Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A44851 | 27062661 | J Hepatol | EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. | 2016 | Details |
| A44852 | 27057871 | Medicine (Baltimore) | Factors Significantly Associated With the Increased Prevalence of Carotid Atherosclerosis in a Northeast Chinese Middle-aged and Elderly Population: A Cross-sectional Study. | 2016 | Details |
| A44853 | 27056462 | Z Gastroenterol | [Expected increase of hepatocellular carcinoma by nonalcoholic fatty liver disease]. | 2016 | Details |
| A44854 | 27056371 | Diabetologia | The liver in focus. | 2016 | Details |
| A44855 | 27055256 | Obes Facts | EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A44856 | 27053233 | Diabetologia | EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: guidelines, clinical reality and health economic aspects. | 2016 | Details |
| A44857 | 27053231 | Diabetologia | EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: disease mongering or call to action? | 2016 | Details |
| A44858 | 27053230 | Diabetologia | EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. | 2016 | Details |
| A44859 | 27048892 | Best Pract Res Clin Gastroenterol | Dysbiosis in gastrointestinal disorders. | 2016 | Details |
| A44860 | 27045249 | Zhejiang Da Xue Xue Bao Yi Xue Ban | [Frontiers of research on nonalcoholic fatty liver disease]. | 2016 | Details |
| A44861 | 27045003 | Hepatology | Prevalence of nonalcoholic fatty liver disease in the middle eastern area: What is the exact estimation? | 2016 | Details |
| A44862 | 27040339 | Yakugaku Zasshi | [Current Status and Future Prospects of Nonalcoholic Fatty Liver Disease (NAFLD) in Japan-Feedback from Clinical and Basic Researches to Medical Therapy and Pharmacist Activities]. | 2016 | Details |
| A44863 | 27038645 | J Hepatol | PNPLA3 gene in liver diseases. | 2016 | Details |
| A44864 | 27038346 | Hepatology | Errors in meta-analysis on prevalence of nonalcoholic fatty liver disease. | 2016 | Details |
| A44865 | 27038241 | Hepatology | Global epidemiology of nonalcoholic fatty liver disease: Meta-analytic assessment of prevalence, incidence, and outcomes. | 2016 | Details |
| A44866 | 30234284 | Trop Gastroenterol | Non-alcoholic steatohepatitis (NASH) in non-obese children. | 2018 | Details |
| A44867 | 30191030 | Hepat Oncol | Identifying patients at risk from nonalcoholic fatty liver-related hepatocellular carcinomas. | 2016 | Details |
| A44868 | 27025686 | J Hepatol | A fatty liver leads to a broken heart? | 2016 | Details |
| A44869 | 27018125 | Am J Gastroenterol | Erratum: Cost-Effective Evaluation of Nonalcoholic Fatty Liver Disease With NAFLD Fibrosis Score and Vibration-Controlled Transient Elastography. | 2016 | Details |
| A44870 | 31041027 | Clin Liver Dis (Hoboken) | Noninvasive evaluation of nonalcoholic fatty liver disease. | 2016 | Details |
| A44871 | 27015732 | J Gastroenterol Hepatol | Oxidized low-density lipoprotein in non-alcoholic steatohepatitis. | 2016 | Details |
| A44872 | 27013659 | J Biol Chem | Liver MicroRNA-291b-3p Promotes Hepatic Lipogenesis through Negative Regulation of Adenosine 5'-Monophosphate (AMP)-activated Protein Kinase α1. | 2016 | Details |
| A44873 | 27013235 | Genes Dev | The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation. | 2016 | Details |
| A44874 | 27010545 | Dig Dis Sci | Screening Strategies for Nonalcoholic Steatohepatitis in High-Risk Individuals: Trimming Away the Fat. | 2016 | Details |
| A44875 | 27010477 | Eur J Gastroenterol Hepatol | Is nonalcoholic fatty liver disease a risk factor for chronic kidney disease? | 2016 | Details |
| A44876 | 27010475 | Eur J Gastroenterol Hepatol | Predictors of steatohepatitis in nonalcoholic fatty liver disease. | 2016 | Details |
| A44877 | 27006250 | Nat Rev Gastroenterol Hepatol | NAFLD: Loss of CD4(+) T cells in HCC. | 2016 | Details |
| A44878 | 26998910 | Hepatology | Predictive roles of gut dysbiosis on the severity of nonalcoholic fatty liver disease. | 2016 | Details |
| A44879 | 26997005 | Indian J Med Res | Gamma glutamyl transferase: A novel cardiovascular outfit for an old liver test. | 2016 | Details |
| A44880 | 26992428 | Gut | Hepatic-specific PPARα-FGF21 action in NAFLD. | 2016 | Details |
| A44881 | 26991537 | Hepatology | The increasing burden of nonalcoholic fatty liver disease among young adults in the United States: A growing epidemic. | 2016 | Details |
| A44882 | 26986756 | Mol Med Rep | Altered function of monocytes/macrophages in patients with autoimmune hepatitis. | 2016 | Details |
| A44883 | 26984853 | Gut | Gut microbiota produce alcohol and contribute to NAFLD. | 2016 | Details |
| A44884 | 26983484 | Zhonghua Gan Zang Bing Za Zhi | [Value of ANI in differentiating between alcoholic liver disease and nonalcoholic fatty liver disease]. | 2016 | Details |
| A44885 | 26972020 | AIDS Res Hum Retroviruses | Fatty Liver in Hispanics with HIV. | 2016 | Details |
| A44886 | 26960172 | J Pediatr Gastroenterol Nutr | Noninvasive Assessment of Nonalcoholic Steatohepatitis and Nonalcoholic Steatohepatitis-Related Fibrosis: Is There a Role for Cytokeratin 18? | 2016 | Details |
| A44887 | 26959309 | Metab Syndr Relat Disord | The Association of Alanine Aminotransferase in Early Pregnancy with Gestational Diabetes. | 2016 | Details |
| A44888 | 26957864 | J Pharm Bioallied Sci | Statins and its hepatic effects: Newer data, implications, and changing recommendations. | 2016 | Details |
| A44889 | 26955824 | Clin Chem | Thrombin Generation Assay and Its Application in the Clinical Laboratory. | 2016 | Details |
| A44890 | 26955295 | Hepat Med | Autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response. | 2016 | Details |
| A44891 | 26950044 | J Dig Dis | Consensus on the diagnosis and treatment of cholestatic liver diseases (2015, China). | 2016 | Details |
| A44892 | 26948494 | J Hepatol | Tiny RNA with great effects: miR-155 in alcoholic liver disease. | 2016 | Details |
| A44893 | 26941826 | Evid Based Complement Alternat Med | Preclinical Models for Investigation of Herbal Medicines in Liver Diseases: Update and Perspective. | 2016 | Details |
| A44894 | 26936934 | J Leukoc Biol | The role of macrophages in obesity-driven chronic liver disease. | 2016 | Details |
| A44895 | 26934416 | Eur J Gastroenterol Hepatol | Betatrophin in nonalcoholic fatty liver disease. | 2016 | Details |
| A44896 | 26926530 | Hepatology | The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health. | 2016 | Details |
| A44897 | 26924096 | Gastroenterology | Extracellular Vesicles as Messengers Between Hepatocytes and Macrophages in Nonalcoholic Steatohepatitis. | 2016 | Details |
| A44898 | 26924092 | Gastroenterology | Regulatory Science and Drug Approval for Alcoholic and Nonalcoholic Steatohepatitis. | 2016 | Details |
| A44899 | 26923311 | Liver Int | Response to The relationship between serum uric acid levels and NAFLD. | 2016 | Details |
| A44900 | 26914713 | Cancer | Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis. | 2016 | Details |
| A44902 | 26905424 | Sci Signal | Mystery solved: Trehalose kickstarts autophagy by blocking glucose transport. | 2016 | Details |
| A44903 | 26902945 | J Hepatol | Clinical Trial Watch: Reports from the Liver Meeting®, AASLD, San Francisco, November 2015. | 2016 | Details |
| A44904 | 26900767 | Rev Esp Enferm Dig | Glycogenic hepatopathy in young adults: a case series. | 2016 | Details |
| A44905 | 26891023 | Hepatology | Nonalcoholic fatty liver disease and elastography: Incremental advances but work still to be done. | 2016 | Details |
| A44906 | 26886387 | Eur J Gastroenterol Hepatol | Uric acid in nonalcoholic fatty liver disease. | 2016 | Details |
| A44907 | 26882878 | Nat Rev Gastroenterol Hepatol | Alcoholic liver disease: Mucosal microbes exacerbate experimental alcoholic steatohepatitis. | 2016 | Details |
| A44908 | 26873400 | Gastroenterology | Clinical Implications of Concomitant Alcohol Use, Obesity, and Viral Hepatitis. | 2016 | Details |
| A44909 | 26860268 | Nat Rev Gastroenterol Hepatol | NASH: NASH and TLR9. | 2016 | Details |
| A44910 | 26858005 | Alcohol Clin Exp Res | Chronic Alcohol Consumption Causes Liver Injury in High-Fructose-Fed Male Mice Through Enhanced Hepatic Inflammatory Response. | 2016 | Details |
| A44911 | 26849851 | Curr Opin Lipidol | Novel therapies for severe dyslipidemia originating from human genetics. | 2016 | Details |
| A44912 | 26847353 | J Gastrointest Surg | Hepatectomy After Yttrium-90 (Y90) Radioembolization-Induced Liver Fibrosis. | 2016 | Details |